Breaking News Instant updates and real-time market news.

BHVN

Biohaven Pharmaceutical

$28.85

0.43 (1.51%)

04:55
01/05/18
01/05
04:55
01/05/18
04:55

Biohaven Pharmaceutical management to meet with William Blair

Meetings to be held in Chicago on January 4 and in Denver on January 5 hosted by William Blair.

  • 05

    Jan

BHVN Biohaven Pharmaceutical
$28.85

0.43 (1.51%)

10/03/17
NEED
10/03/17
NO CHANGE
NEED
Biohaven Pharmaceutical price target lowered to $36 from $43 at Needham
Needham analyst Alan Carr cut his price target on Biohaven after the company's trigriluzole drug missed its primary endpoint in a Phase 2/3 trial. The analyst removed the drug from his model but remains upbeat on the outlook for the Phase 3 trial of the company's trigriluzole drug, whose data is due out in 1Q18. He keeps a Buy rating on the shares.
12/11/17
PIPR
12/11/17
NO CHANGE
Target $48
PIPR
Overweight
Piper defends Biohaven shares after management meeting
Piper Jaffray analyst Charles Duncan says he's defending Biohaven Pharmaceutical shares after meeting with the company's management. The analyst has "reaffirmed conviction" on the company's clinical progress in 2018 and believes three sources of market inefficiency will be addressed in the near-term. First, he believes the migraine market opportunity for rimegepant is greater than $1B. Second, Duncan sees rimegepant as relatively risk-reduced and does not expect a signal to emerge in its long-term studies. Third, the analyst thinks the glutamate platform will become a value driver yet again during 2018. He reiterates an Overweight rating on Biohaven with a $48 price target.
12/15/17
ADAM
12/15/17
INITIATION
Target $30
ADAM
Buy
Biohaven Pharmaceutical initiated with a Buy at Canaccord
Canaccord initiated Biohaven Pharmaceutical with a Buy and $30 price target.
12/18/17
MSCO
12/18/17
NO CHANGE
MSCO
Morgan Stanley sees opportunities in biotech amid 'limited' investor conviction
With clinical catalysts in large-cap Biotechnology limited to only five key Phase III readouts - three of which are from Alexion (ALXN) - investors are describing their 2018 picks in the space as the "least worst" of the group, according to Morgan Stanley analyst Matthew Harrison. However, he believes this lack of conviction creates real opportunity for outsized moves in 2018, with Amgen (AMGN) identified by Harrison as the biggest potential beneficiary of M&A given "its likely newfound access" to about $39B in offshore cash. Other biotech names the analyst highlights on the up side include Biogen (BIIB), BioMarin (BMRN), Biohaven (BHVN) and Sarepta (SRPT). Meanwhile, Harrison highlights his concerns about potential downside for BioVerativ (BIVV) and Innoviva (INVA), on both of which he keeps Underweight ratings.

TODAY'S FREE FLY STORIES

INTC

Intel

$48.12

1.03 (2.19%)

16:31
11/15/18
11/15
16:31
11/15/18
16:31
Hot Stocks
Intel board approves $15B increase in authorized stock repurchase program »

Intel Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

TGT

Target

$80.76

-2.35 (-2.83%)

16:31
11/15/18
11/15
16:31
11/15/18
16:31
Initiation
Target initiated  »

Target initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 03

    Mar

NVDA

Nvidia

$202.65

5.43 (2.75%)

16:30
11/15/18
11/15
16:30
11/15/18
16:30
Hot Stocks
Nvidia board authorizes additional $7B under share buyback program »

In November 2018,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 19

    Nov

  • 26

    Nov

  • 10

    Dec

LTRX

Lantronix

$3.51

0.03 (0.86%)

16:30
11/15/18
11/15
16:30
11/15/18
16:30
Syndicate
Breaking Syndicate news story on Lantronix »

Lantronix files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

NVDA

Nvidia

$202.65

5.43 (2.75%)

16:30
11/15/18
11/15
16:30
11/15/18
16:30
Hot Stocks
Nvidia raises quarterly dividend 7% to 16c per share »

Nvidia announced a 7%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 19

    Nov

  • 26

    Nov

  • 10

    Dec

16:30
11/15/18
11/15
16:30
11/15/18
16:30
Options
Preliminary option volume of 24.1M today »

Preliminary option volume…

GOGL

Golden Ocean

$6.68

0.19 (2.93%)

, SALT

Scorpio Bulkers

$5.71

0.115 (2.06%)

16:29
11/15/18
11/15
16:29
11/15/18
16:29
Initiation
Golden Ocean, Scorpio Bulkers initiated  »

Golden Ocean, Scorpio…

GOGL

Golden Ocean

$6.68

0.19 (2.93%)

SALT

Scorpio Bulkers

$5.71

0.115 (2.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVDA

Nvidia

$202.65

5.43 (2.75%)

16:28
11/15/18
11/15
16:28
11/15/18
16:28
Earnings
Nvidia sees Q4 revenue $2.7B, +/- 2%, consensus $3.4B »

GAAP and non-GAAP gross…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 19

    Nov

  • 26

    Nov

  • 10

    Dec

NVDA

Nvidia

$202.65

5.43 (2.75%)

16:27
11/15/18
11/15
16:27
11/15/18
16:27
Earnings
Nvidia reports Q3 adjusted EPS $1.84, consensus $1.71 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 19

    Nov

  • 26

    Nov

  • 10

    Dec

NCS

NCI Building

$12.25

-0.095 (-0.77%)

16:26
11/15/18
11/15
16:26
11/15/18
16:26
Hot Stocks
NCI Building shareholders vote in favor of merger with Ply Gem »

NCI Building's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

MTEM

Molecular Templates

$4.53

0.12 (2.72%)

16:26
11/15/18
11/15
16:26
11/15/18
16:26
Initiation
Molecular Templates initiated  »

Molecular Templates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WES

Western Gas Partners

$44.45

-0.13 (-0.29%)

16:25
11/15/18
11/15
16:25
11/15/18
16:25
Hot Stocks
Western Gas Partners announces management changes, promotions »

Western Gas Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

BGCP

BGC Partners

$10.66

0.24 (2.30%)

16:25
11/15/18
11/15
16:25
11/15/18
16:25
Hot Stocks
Breaking Hot Stocks news story on BGC Partners »

Point72 Asset Management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APC

Anadarko

$55.49

1.09 (2.00%)

16:25
11/15/18
11/15
16:25
11/15/18
16:25
Hot Stocks
Anadarko raises dividend 20% to 30c per share »

On Nov. 15, 2018,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:25
11/15/18
11/15
16:25
11/15/18
16:25
Conference/Events
UBS MLPs & Natural Gas Analyst to hold a group dinner »

MLPs & Natural Gas…

GNBC

Green Bancorp

$18.71

0.53 (2.92%)

, VBTX

Veritex

$23.60

0.66 (2.88%)

16:25
11/15/18
11/15
16:25
11/15/18
16:25
Conference/Events
Green Bancorp to host special shareholder meeting »

Special Shareholder…

GNBC

Green Bancorp

$18.71

0.53 (2.92%)

VBTX

Veritex

$23.60

0.66 (2.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 15

    Nov

MATW

Matthews

$40.30

-1 (-2.42%)

16:24
11/15/18
11/15
16:24
11/15/18
16:24
Hot Stocks
Matthews sees FY19 adjusted EBITDA growth in mid-to-high single digits »

Matthews' president…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Nov

  • 28

    Nov

MATW

Matthews

$40.30

-1 (-2.42%)

16:23
11/15/18
11/15
16:23
11/15/18
16:23
Earnings
Matthews reports Q4 adjusted EPS $1.23, consensus $1.21 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Nov

  • 28

    Nov

TGT

Target

$80.76

-2.35 (-2.83%)

16:23
11/15/18
11/15
16:23
11/15/18
16:23
Initiation
Target initiated  »

Target initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 03

    Mar

DCPH

Deciphera

$22.61

1.99 (9.65%)

16:22
11/15/18
11/15
16:22
11/15/18
16:22
Hot Stocks
Deciphera completes enrollment in INVICTUS pivotal Phase 3 study »

Deciphera Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

GLOB

Globant

$52.64

1.78 (3.50%)

16:22
11/15/18
11/15
16:22
11/15/18
16:22
Earnings
Globant sees FY18 adjusted EPS $1.69-$1.73, consensus $1.68 »

Sees FY18 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 27

    Nov

  • 28

    Nov

  • 02

    Dec

SALT

Scorpio Bulkers

$5.71

0.115 (2.06%)

16:22
11/15/18
11/15
16:22
11/15/18
16:22
Initiation
Scorpio Bulkers initiated  »

Scorpio Bulkers initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAIC

SAIC

$69.65

1.74 (2.56%)

, EGL

Engility

$31.14

0.86 (2.84%)

16:22
11/15/18
11/15
16:22
11/15/18
16:22
Hot Stocks
Engility, SAIC to hold special meetings on January 11 to approve merger »

Science Applications…

SAIC

SAIC

$69.65

1.74 (2.56%)

EGL

Engility

$31.14

0.86 (2.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

MATW

Matthews

$40.30

-1 (-2.42%)

16:21
11/15/18
11/15
16:21
11/15/18
16:21
Hot Stocks
Matthews raises quarterly dividend 5.3% to 20c per share »

Matthews International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Nov

  • 28

    Nov

GOGL

Golden Ocean

$6.68

0.19 (2.93%)

16:21
11/15/18
11/15
16:21
11/15/18
16:21
Initiation
Golden Ocean initiated  »

Golden Ocean initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.